Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-23-011074

CVP,Strategy/Corp Development sold 8,000 shares at $71.86 ($574,880)

  • CVP,Strategy/Corp Development acquired 8,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BOBO DONALD E JR · CVP,Strategy/Corp Development

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-12-13 Exercise or conversion : show line 1 in the form 10b5-1 +8,000 $36.75 $294,000 47,502.69 D
2023-12-13 Sale : show line 2 in the form 10b5-1 −8,000 $71.86 $574,880 39,502.69 D
Open-market sales · 8,000 sh · avg $71.86 · $574,880

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-12-13 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) −8,000 $36.75 2024-05-10 8,000 48,000 D
Loading xslF345X05/doc4.xml…